Hot Life Science Investor Mandate 4: Midwest VC Invests in Medtech with IT Component

24 Dec

A Chicago-based VC firm is investing from a $250m fund, and is interested in a variety of sectors including the life science field. For life science investments, the firm typically allocates $2-15 million, and prefers to invest in Series B-C rounds. The firm invests in the USA and Canada.

The firm is presently focused on technologies that involve an IT/software component, across the medical devices, diagnostics, and healthcare services sectors in addition to pure digital health opportunities. The firm is open to opportunities in any clinical indication. The firm is only interested in devices and diagnostics that have in-human data.

In the life science sector, the firm is not interested in early-stage opportunities; however the firm is open to both companies with an approved product on the market, and companies with a product in late-stage clinical trials. The firm takes the strength of the management team into consideration.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: